We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
+33.19%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.8B
AUM Growth
+$158M
Cap. Flow
-$258M
Cap. Flow %
-9.21%
Top 10 Hldgs %
41.71%
Holding
75
New
23
Increased
16
Reduced
15
Closed
19

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$125M
2
TFX icon
Teleflex
TFX
+$107M
3
HOLX
Hologic
HOLX
+$82.4M
4
NVST icon
Envista
NVST
+$72.4M
5
LH icon
Labcorp
LH
+$63.8M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$124M
2
EW icon
Edwards Lifesciences
EW
+$115M
3
BAX icon
Baxter International
BAX
+$90.3M
4
MRK icon
Merck
MRK
+$88.2M
5
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
+$85.5M

Sector Composition

Rank Sector Weight
1 Healthcare 92.07%
2 Technology 1.67%
3 Industrials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVET
51
PUT
DELISTED
Covetrus, Inc. Common Stock
CVET
$6.6M 0.24%
+500,000
New +$6.05M
SRPT icon
52
Sarepta Therapeutics
SRPT
$1.71B
$6.49M 0.23%
+50,280
New +$5.07M
MDCO
53
PUT
DELISTED
Medicines Co
MDCO
$6.37M 0.23%
+75,000
New +$5M
SRGA
54
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$5.92M 0.21%
71,955
– –
DERM
55
DELISTED
Dermira, Inc.
DERM
$5.52M 0.2%
+364,227
New +$3.14M
PTE
56
DELISTED
PolarityTE, Inc. Common Stock
PTE
$1.65M 0.06%
25,444
– –
ABT icon
57
Abbott
ABT
$184B
– –
-756,400
Closed -$63.3M
ALC icon
58
Alcon
ALC
$34.5B
– –
-558,940
Closed -$32.6M
BAX icon
59
Baxter International
BAX
$14.3B
– –
-1,032,820
Closed -$90.3M
BIIB icon
60
CALL
Biogen
BIIB
$30.6B
– –
-550,000
Closed -$128M
BIIB icon
61
Biogen
BIIB
$30.6B
– –
-356,860
Closed -$83.1M
BMY icon
62
CALL
Bristol-Myers Squibb
BMY
$135B
– –
-400,000
Closed -$20.3M
BSX icon
63
Boston Scientific
BSX
$70.7B
– –
-961,820
Closed -$39.1M
GMAB icon
64
Genmab
GMAB
$17.8B
– –
-696,835
Closed -$14.1M
PSNL icon
65
Personalis
PSNL
$1.45B
– –
-283,500
Closed -$4.16M
QGEN icon
66
Qiagen
QGEN
$8.66B
– –
-579,140
Closed -$20.2M
SEM
67
DELISTED
Select Medical
SEM
– –
-1,531,014
Closed -$13.7M
NGM
68
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-316,679
Closed -$4.39M
NUVA
69
DELISTED
NuVasive, Inc.
NUVA
– –
-300,905
Closed -$19.1M
CLVS
70
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-1,491,376
Closed -$5.86M
MYOK
71
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-282,090
Closed -$14.7M
WMGI
72
DELISTED
Wright Medical Group Inc
WMGI
– –
-2,062,360
Closed -$42.5M
STML
73
DELISTED
Stemline Therapeutics, Inc.
STML
– –
-1,243,780
Closed -$12.9M
CVRS
74
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
– –
-19,981,655
Closed -$85.5M
HZNP
75
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-2,628,840
Closed -$71.6M
1 2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q4 2019 Portfolio in Review

As of Q4 2019, HealthCor Management held 75 positions worth $2.8B, up 6% from $2.65B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

HealthCor Management withdrew a net $258M in Q4 2019, closing 19 positions and reducing 15 holdings. Its most notable exit was Baxter International, an estimated $90.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 90% a quarter earlier, followed by Technology and Industrials.

Against the trend, HealthCor Management opened a new position in Regeneron Pharmaceuticals worth $140M.

  • HealthCor Management's largest Q4 2019 buy was Regeneron Pharmaceuticals: 372,770 shares worth $140M.
  • HealthCor Management added most to Hologic in Q4 2019, an estimated $82.4M increase.
  • HealthCor Management's biggest Q4 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $124M.
  • HealthCor Management fully exited Baxter International in Q4 2019, selling an estimated $90.3M.
  • HealthCor Management's ten largest holdings make up 42% of its $2.8B portfolio in Q4 2019.
  • HealthCor Management opened 23 new positions and closed 19 in Q4 2019.
  • HealthCor Management's portfolio value rose 6% quarter-over-quarter to $2.8B.

Based on HealthCor Management's 13F filing for Q4 2019, filed 14 Feb 2020.